Cargando…
Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
BACKGROUND AND OBJECTIVE: Neuromyelitis optica spectrum disorders (NMOSD) are chronical inflammatory demyelinating diseases of the central nervous system (CNS) and the underlying mechanism remains unclear. Several recent studies have demonstrated that T cells play a pivotal role in the pathogenesis...
Autores principales: | Shi, Ziyan, Du, Qin, Wang, Xiaofei, Wang, Jianchen, Chen, Hongxi, Lang, Yanling, Kong, Lingyao, Luo, Wenqin, Yang, Mu, Zhou, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682179/ https://www.ncbi.nlm.nih.gov/pubmed/36439094 http://dx.doi.org/10.3389/fimmu.2022.1027158 |
Ejemplares similares
-
Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models
por: Luo, Wenqin, et al.
Publicado: (2023) -
Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022) -
Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder
por: Luo, Wenqin, et al.
Publicado: (2023) -
The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases
por: Wang, Xiaofei, et al.
Publicado: (2022) -
Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
por: Kong, Lingyao, et al.
Publicado: (2022)